Profile
Marc J.
Lajoie is the founder of GRO Biosciences, Inc. (founded in 2016) and holds the title of Advisor.
Dr. Lajoie is also the founder of Outpace Bio, Inc...
Marc J. Lajoie active positions
| Companies | Position | Start |
|---|---|---|
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Founder | 31/12/2015 |
Outpace Bio, Inc.
 Outpace Bio, Inc. BiotechnologyHealth Technology Outpace Bio, Inc. is a company that creates smart cell therapies using protein design and synthetic biology to reprogram how cells function and make decisions. The company is based in Seattle, WA. The company collaborates with industry leaders to improve the safety and efficacy of cell and gene therapies. Outpace's platform combines the design of improved biological functions with powerful cellular control modalities to tackle incurable diseases. Outpace Bio was founded by Marc J. Lajoie and Scott Boyken, and Marc J. Lajoie has been the CEO since incorporation. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Outpace Bio, Inc.
Outpace Bio, Inc. BiotechnologyHealth Technology Outpace Bio, Inc. is a company that creates smart cell therapies using protein design and synthetic biology to reprogram how cells function and make decisions. The company is based in Seattle, WA. The company collaborates with industry leaders to improve the safety and efficacy of cell and gene therapies. Outpace's platform combines the design of improved biological functions with powerful cellular control modalities to tackle incurable diseases. Outpace Bio was founded by Marc J. Lajoie and Scott Boyken, and Marc J. Lajoie has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Marc J. Lajoie
